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Introduction: The levels of Biomarkers such as interleukin 12 (IL-12) are elevated in patients with 
Multiple Sclerosis (MS). The aim of the present study was to compare the effectiveness of 
Cognitive-Behavioral Stress Management (CBSM) training and Acceptance and Commitment 
Therapy (ACT) on IL-12 in Multiple Sclerosis (MS) patients. 
Methods: The present study was a quasi-experimental design with pretest-posttest and follow-up 
with control group. The statistical population included all female patients with Relapsing–Remitting 
MS who had referred to Multiple Sclerosis Research Center of Tehran University of Medical 
Sciences in Sina Hospital. 30 patients were selected by convenient sampling method and were 
replaced randomly into two experimental groups and one control group (each group included 10 
patients). One of the experimental groups received the CBSM training and another experimental 
group received the ACT. To measure IL-12, the Enzyme-Linked Immunosorbent Assay (ELISA) 
was used. The data were analyzed using Analysis of Variance (ANOVA) with repeated 
measurement. 
Results: The results showed that ACT had no significant effect on IL-12 (p>0.05), but CBSM 
training significantly reduced IL-12 and these results remained in the follow-up period (p<0.001). 
Discussion: Relaxation techniques in CBSM can increase diaphragmatic breathing and decrease 
stress experience, including cortisol levels and stress. Subsequently, physiological symptoms reduce 
stress and thus affect the level of biomarkers like IL-12. Therefore, it can be useful in improving 
biological parameters in patients with MS. 
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   Introduction 
   Multiple Sclerosis (MS) is an 
inflammatory disease of the central nervous 
system that destroys the myelin sheath in the 
brain and spinal cord (1). Women are 
approximately 2–3 times more likely to 
suffer from MS, and most patients are 20 to 
50 years old (2). Residents of Eastern 
Europe are more likely to suffer from MS 
compared with residents of Asia, Africa and 
Latin America (3, 4). MS causes to the 
impairment of the sensory system, including 
numbness or paresthesia; impaired motor 
function including weakness or spasm; eye, 
bowel and bladder dysfunction, cognitive 
and fatigue disorders (5), and psychological 
disorders such as stress (6). MS can have an 
effect on  the levels of biomarkers such as 
Interleukins 12. (7) 
Interleukins (IL) are cytokines made by 
white blood cells that often affect other 
leukocytes (8). Cohen and Herbert (8) have 
suggested that assessing the concentration of 
cytokines is an appropriate method for 
examining the underlying mechanisms of 
immune disorders in stress. Biomarkers can 
identify disease progression or therapeutic 
effects (9).  Researchers such as Alxander et 
al., 2010 & Van Boxel-Dezaire et al., 1999, 
have linked IL-12 levels to disease activity 
and changes in magnetic resonance imaging 
(10, 11). People with MS have been shown 
to have higher levels of Il-12, and this 
marker predicts correctly in 81% of patients 
(12). The findings of Özenci et al. (13) 
corroborated this system in MS patients. 
Van Boxel-Dezaire (11) showed that there is 
a significant increase in the expression of 
Interleukin-12 by peripheral blood 
mononuclear cells before recurrence. In the 
research of Losy et al. (7), there is 
significant increase in interleukin-12 in 
relapsing-remitting stage disease as well as 
in primary cases and secondary forms (14). 
Biological processes in MS can be 
influenced by psychological variables such 
as stress, psychological distress, or even 
exposure to disease such as acceptance, so 
psychological treatments may be effective 
on these biological processes of MS, 
Numerous studies have shown the 
association between physical stress or 
stressors and psychological distress with 
levels of interleukins (15,16,17,18).  
   Cognitive-behavioral Stress Management 
(CBSM) is one of the psychological 
therapies developed for people who are 
struggling with the stress of chronic and 
severe physical illness (19). CBSM can 
relax and reduce stress and effectively cope 
with problems through techniques such as 
relaxation training, meditation, and 
biofeedback (19). This program is a 
combination of relaxation and cognitive-
behavioral techniques that are integrated 
into CBSM intervention (20).  
   Other therapies that have been effective in 
patients with MS, are Acceptance and 
Commitment Therapy (ACT) (21). Research 
has shown that ACT has been effective in 
improving the psychological problems of 
patients with MS and these improvements 
have been sustained (22, 23). ACT was first 
developed by Steven Hayes in 1986 (24). 
This method is part of the third wave of 
behavioral therapies followed by the second 
wave of these therapies, such as Cognitive-
Behavioral therapy (CBT) and it is one of 
the recent expanded models whose key 
therapeutic processes differ from traditional 
CBT (25). ACT is a third-wave behavior 
therapy that explicitly embraces this 
approach of changing thoughts and feelings 
rather than their content or frequency, and 
the underlying principles include: 1- 
Acceptance, or willingness to experience 
pain or other disturbing events without 
attempting to inhibit them. 2. Value-based 
action or commitment with a desire to act as 
meaningful personal goals rather than 
eliminating unwanted experiences in 
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interacting with other nonverbal attachments 
in a way leading to healthy functioning (25). 
This method includes exposure-based 
experiences and exercises, linguistic 
metaphors, and techniques such as mental 
relaxation (25). The main goal of acceptance 
and commitment therapy is to provide some 
kind of psychological flexibility. 
Psychological flexibility means the ability to 
choose the action that is most appropriate 
among the various options, rather than doing 
something that is only to avoid disturbing 
thoughts, feelings, memories, or desires 
(26).  
Some studies of the effects of CBT on the 
reduction of inflammatory cytokines such as 
Interleukin-6 in patients with major 
depressive disorder (27) and inflammatory 
cytokines in insomnia patients (28) as well 
as the effect of CBSM. A CBSM training 
done by phone has revealed a decrease in 
inflammatory cytokines including IL-13 
(29). ACT has been associated with reduced 
anxiety, depression, and stress in patients 
with Multiple Sclerosis (30). Stress, 
depression, and anxiety and levels of 
interleukins are related (31, 32, 33). 
Therefore, ACT may also decrease 
interleukin-12 levels by reducing stress, 
anxiety, and depression. Although these 
studies have revealed the effects of these 
two therapies on biomarkers and 
psychological distress, there is no research 
that directly examines these two therapies on 
interleukin 12 in MS patients. Therefore, 
this study was the first to address the general 
question of whether CBSM training and 
ACT can influence biomarkers such as 
Interleukin 12 in MS patients, and whether 
there is a difference between the two 
treatments in the effectiveness of this 
biomarker. 
   Method  
The present study was a quasi-experimental 
design with pre-test, post-test and two-
month follow-up with control group. The 
statistical population consisted of all female 
patients with relapsing-remitting MS who 
referred to MS Research Center of Tehran 
University of Medical Sciences in Sina 
Hospital between January 2019 to June 
2019. The McDonald Criteria (2017) was 
the basis for the Diagnosis of Multiple 
Sclerosis (34). Patients were selected and 
randomly assigned to the first experimental 
group (n = 10), the second experimental 
group (n = 10), and the control group (n = 
10). The first experimental group underwent 
8 weekly sessions (90 minutes each session) 
of CBSM training based on therapeutic 
guidelines of Anthoni, Ironson & 
Schneidermann (20), the second 
experimental group received eight 90-
minute sessions of ACT Based on Hayes 
(24), and the control group was placed on 
the waiting list. The sessions were held at 
the Sina Hospital of Neuroscience Research 
Center of Tehran University of Medical 
Sciences. Inclusion criteria included 
definitive diagnosis of Relapsing-Remitting 
MS by a neurologist, failure to receive 
psychological treatment for the past 3 
months, receiving the same medical 
treatment, no psychiatric disorders, no use of 
psychotropic drugs, no other physical 
illnesses affecting patients, and informed 
consent to participate in the study. Exclusion 
criteria included having psychiatric illnesses 
and other physical ailments, not attending 
training sessions for more than two sessions, 
refusing to participate in research and 
receiving psychological therapies for any 
reason. CBSM Training was summarized as 
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Introduction, introducing the first component of stress management (including being aware 




Training on the impact of stress on thinking patterns, emotional conditions, behavior, 
physical sensations, stress, and patient relationships 
 
Third session 
Teaching the interplay of thoughts, emotions, and physical senses together, and learning 




Introduce common types of negative thinking and cognitive distortions 
 
Fifth session 
Emphasize replacing logical thoughts with irrelevant thoughts and teaching five steps to 
replace logical thoughts 
 
Sixth session 
Learning to use the techniques learned in life and defining "coping" and introducing 
effective and ineffective coping strategies 
Seventh session Introducing and training steps for an effective 
 
Eighth session 
Program subjects became aware of their raw anger responses and patterns and learned 
better ways to manage anger, post-test. 
 
Patients in the second intervention group 
participated in 8 sessions of ACT. Table 2  
 
presents a description of these 8 sessions. 
 








Exploring the inner and outside worlds in act, developing a desired ineffective program 
(behavior change), changing and understanding that problem control is not a solution, and 
introducing alternatives to control, introducing homework 
Third session Identifying people's values, defining values, defining goals and defining obstacles, 
explaining the concept of acceptance and differing from the concepts of failure, despair, 
denial and resistance, acceptance is a perpetual, not a cross-cutting, process. On the 
challenges of acceptance, summary, and homework assessment 
 
Fourth session 




Demonstrate self-separation, internal experiences and behavior, introduce and conceptualize 




Commitment and self-observation, identifying patients' living values and reflecting on these 
values, summarizing and presenting homework 
 
Seventh session 
Mindfulness and emphasis on the present time, investigating the values of each person and 
deepening previous concepts, listing the most important values of the subjects and possible 
barriers to their follow-up, summarizing and homework presentation 
 
Eighth session 
Understanding the nature of willingness and commitment (commitment to action training), 
identifying values and commitment behavior plans, investigating life and commitment 
action stories, completing treatment, and post-test. 
 
In order to adhere to the research ethics, 
participants were asked to participate in 
research and training sessions willingly and 
were told that their information would be 
kept confidential by the researchers. In this 
research, repeated measure Analysis of 
Variance was used for data analysis in 
SPSS-22 software. 
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Measurement In this study, a laboratory 
instrument was used to measure interleukin 
12. 
Measurement of IL-12 (ELISA): ELISA is 
a biochemical technique mainly used in 
immunity to measure interleukin 12 in 
experimental and control groups in pre-test, 
post-test and follow-up stages. Oncology is 
used to identify the presence of an antibody 
or antigen in a sample, ELISA is based on 
the binding of the antibody and the antigen, 
and this process is performed on a bed of a 
material with a high binding ability to the 
protein and having an adsorbing role. This 
bed is a 96-sheet pallet with 12 * 8 matrix, 
each one centimeter high and 0.7 centimeter 
in diameter. The advantages of ELISA are 
its high sensitivity, its quantitative and 
repeatability. Primary IL-12 levels were 
calculated by the device as well as after the 
intervention and after the 60-day follow-up 
period. Serum IL-12 levels were measured 
from the blood samples of patients with MS 
participating in the present study in pre-test, 
post-test and follow-up. In this method, 
blood samples were separated by serum 
centrifugation and stored in a freezer at -
18°C. Then IL-12 levels were analyzed and 
analyzed only on the duplicate samples 
taken prior to each of the three stages (pre-
test, post-test, and follow-up). IL-12 levels 
were recorded in all three stages of pre-test, 









Table 3: Demographic Characteristics 
































































CBSM 31.6 6.74 3 7 - 4 4 2 24.3 3.47 7.3 4.83 
ACT 36.2 9.31 2 8 - 4 5 1 28.9 7.45 03/8 5.44 
Control 33.9 6.08 4 6 - 4 6 - 27.6 5.19 6.3 3.27 
 
The mean and standard deviation of the IL-
12 dependent variable in the pre-test, post- 
 
 
test and follow-up in the experimental and 
control groups are presented in Table 4. 
 
Table 4: Mean and standard deviation of pre-test, post-test and follow-up of IL-12 variable follow-up by 
experimental and control groups.  









CBSM 55.6 6.77 36.76 5.98 37.17 5.77 
ACT 54.05 6.64 51.61 7.27 52.01 7.15 




According to Table 4, which shows the 
mean and standard deviation of the study 
groups in the three stages of pre-test, post-
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test, and follow-up, the mean IL-12 scores at 
post-test (36.76) and follow-up (37.17). 
Compared to the pre-test (55.61) in the 
CBSM training group. Also, IL-12 scores in 
posttest (51.61) and follow-up (52.01) 
compared to pre-test (54.05) did not change 
significantly in ACT group. The mean 
scores of the control group were equal in 
pre-test, post-test, and follow-up on this 
variable. 
ANOVA with repeated measures was used 
to compare the means of the groups in the 
three stages of pre-test, post-test and follow-
up. Prior to performing the analysis of 
variance with repeated measures, the tests of 
MBB, Kravitz and Levine tests were 
performed to observe the assumptions. The 
results of these tests to compare the efficacy 
of two therapeutic interventions on 
Interleukin 12 showed that the non-
significant results of boxing tests (p <0.05, F 
= 1.48) and Levin in pre-test (0.09). Post-
test (p = 0.10, F = 2.53), and follow-up (p = 
0.08, F = 2.75) (p = 0.08) (p = 0.05) 
confirms the assumptions of homogeneity of 
variance-covariance matrices and intergroup 
variance homogeneity 
Also, the significant results of the Mokheli 
Sphericity test on the homogeneity of intra-
group variances for Interleukin 12 showed 
no sphericity. Therefore, the Gaussian 
Greenhouse Modification was used to report 
on the intra-group effects. According to 
confirmation of the hypotheses, repeated 
measures Analysis of Variance was used to 
compare the effectiveness of the two 
interventions on research variables and the 
results are presented in Tables 5, 6 and 7. 
 
Table 5: Results of repeated measures analysis of variance for intergroup effects of time and group interaction on 
IL-12 
 













0.03 497.55 2 26  0.001 0.98 
Interference of 
Time and Group 
Wilks 
Lambda 
0.02 88.7 4 52  0.001 0.87 
  
 
According to the results of Table 5, the 
results of Lambda Wilks test showed that 
the effect of time and group interaction on 
IL-12 was significant (p <0.001, F = 88.70). 
The variance of group scores is related to 
group membership. According to the results 
of the above test, repeated measures analysis 
of variance can be used to evaluate the 




Table 6: Intra-group and inter-group effects test results using repeated measures analysis of variance on IL-12 levels 
 








Squares   
F Significance Eta 
 
Inter-group 
IL-12 Time of 
Measurement 
950.39 2 475.19 865.01 0.001 0.97 
Time×Group 1403.18 4 350.8 638.56 0.001 .983 





Constant Value 238403.79 1 238403.79 679.4 0.001 0.96 
Group 3653.47 2 1826.74 5.21 0.01 0.28 
Error 3090.03 27     
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Table 6 presents the results of the effects of 
CBSM training on ACT on IL-12. Based on 
these results, the intra-group effects of 
measurement time (p = 0.001, F = 865/01) 
and time and group interaction (p = 0.001, f 
= 638.56) as well as the intergroup effects (P 
<0.01, F = 5.21) for the Interleukin 12 
variable showed a significant difference in 
Il-12 scores at least between one or both 
groups of CBSM and ACT with the group 
There is evidence and the chi-square values 
indicate acceptable intra-group effect size of 
measurement time (ɳ2 = 0.97) and time-
group interaction (ɳ2 = 0.98) and intergroup 
(ɳ2 = 0.28). (ɳ2 >14) (Table 6). 
Bonferroni post hoc test was used to 
evaluate the difference between the 
effectiveness of the intervention on IL-12, 
the results of which are presented in Table 6. 
 
 
Table 7: Bonferroni follow-up test results for pairwise comparisons of mean IL-12 scores 
 








CBSM ACT -9.37 4.84 0.19 
Control -15.49 4.84 0.01 
 
ACT 
CBSM 9.37 4.84 0.19 
Control -6.12 4.84 0.65 
 
Control 
CBSM 15.49 4.84 0.01 
ACT 6.11 4.84 0.65 
 
Table 7 shows the results of paired 
comparison of the mean IL-12 scores 
between the experimental and control 
groups. The results showed that there was a 
significant difference between the mean 
scores of IL-12 in the CBSM training group 
and the control group (p <0.01). But there 
was no significant difference between the 
IL-12 scores of the ACT group and the 
control group (meandiff = -12.12, p <0.05). 
That is, IL-12 scores were significantly 
reduced only in the CBSM training group 
compared to the control group, and these 
changes remained in the follow-up period. 
The results also showed that there was no 
significant difference between the 
effectiveness of the two interventions 
(meandiff = 9.37, p <0.05). 
 
Discussion and Conclusion 
The present study compared the 
effectiveness of CBSM with ACT based on 
IL-12 for the first time. Repeated measures 
ANOVA were used to evaluate the 
effectiveness of CBSM and ACT on Il-12  
 
levels. The results showed that only CBSM 
intervention resulted in a decrease in Il-12 
and there was no significant difference 
between their efficacies. Also, these changes 
remained stable over time. 
MS is a disease in which stress plays a 
major role, and evidence suggests that 
assessing the concentration of cytokines is 
an appropriate method for examining the 
underlying mechanisms of immune 
abnormalities in stress (8). People with 
AMS have higher levels of IL-12, and this 
biomarker predicts correctly in 81% of 
patients (12). Also, evidence has shown that 
there is a significant increase in Il-12 in the 
recurrent stage of STD (7) as well as in 
primary cases and secondary forms (14).  
Although no research has been conducted on 
the effectiveness of CBSM on biomarkers 
such as interleukin 12 and this study first 
examined the effects of this intervention on 
IL-12 in MS patients, the results of some 
studies are consistent with our results. 
Cognitive-behavioral stress management 
influenced IL-12 depletion. For example, 
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Hall showed that CBSM training could 
reduce IL-6 in people with chronic fatigue 
syndrome (35). Moreira showed that CBT 
was able to decrease inflammatory cytokines 
such as IL-6 in patients with major 
depressive disorder (27). Lattie showed that 
treatment of CBSM treatment by phone 
reduced IL-13 (29). Berk showed that CBT 
was able to reduce stress-related biomarkers 
such as interleukins 4, 6, and 10 in patients 
with major depression and chronic medical 
conditions (36). A research by Chen et al., 
2011, reported that CBT reduced 
inflammatory cytokines such as IL-18 in 
hemodialysis patients (37).  
Although no research has been done on the 
efficacy of acceptance-based therapy on IL-
12, but inconsistent with the results of the 
present study, one study found that 
Acceptance-based therapy improved 
biomarkers such as heart rate, blood 
pressure, fasting blood sugar, Salivary 
telomere length, Il-6, cortisol and alpha 
amylase were found in breast cancer patients 
(38). Also, another study showed that ACT 
improved biological parameters such as 
systolic and diastolic blood pressure and 
cortisol in patients with major hypertension 
(39). However, this study found that ACT 
had no role in reducing IL-12, and only 
CBSM was able to decrease IL-12. Thus, 
these results can be said to play a key role in 
stress disorder, and also that stress and 
psychological distress are correlated with 
levels of interleukins (31, 32, 33), CBSM 
may have reduced IL-12 in MS patients 
through its effect on stress reduction. 
Numerous studies have shown the 
association between stresses or physical and 
psychological stressors with levels of 
interleukins (15, 16, 40, 41 and 42). CBSM 
leads to relaxation and stress reduction and 
effective coping with problems, through 
techniques such as sedation training, 
meditation, and biofeedback (19). Stress as a 
multidimensional and multidimensional 
phenomenon can be a complication of 
EMAS as well as a factor in the 
exacerbation and recurrence of symptoms 
due to illness (15). Stress management 
training may be provided by empowering 
patients with MS to cope with their illness, 
learning about sources of stress, and training 
effective coping skills, including problem 
solving training, muscle relaxation skills and 
modifying maladaptive cognitive 
assessments using cognitive reconstruction 
may help modulate stress-affected 
biomarkers. CBSM program enhances 
individuals' ability to reduce stress and adapt 
to stressful situations (19). 
Stress Management interventions, CBT, or 
CBSM training may be appropriate 
strategies for positive change in patients 
with MS (43) and reduction of inflammatory 
cytokines (28, 44). Research has shown that 
stress-reduction therapies such as CBSM 
training and mindfulness-based stress 
reduction have improved biological markers 
such as interleukin 6 reduction in people 
with essential hypertension (45). Given that 
immune system dysfunction is one of the 
most important etiologic factors in this 
disease, it has recently been suggested that 
stress may exert an adverse effect on the 
course of these diseases through 
exacerbation of cognitive immune 
dysfunction and impact on the cytokine 
network. And intensifies disease activity 
(46, 47). CBSM training is taught to 
participants in the relaxation techniques 
group. Training in relaxation techniques 
enables individuals to recognize physical 
symptoms of stress and to learn how to 
control physical symptoms of stress by 
mastering the relaxation and use of these 
techniques (48). Because physiological 
responses to stress can occur in a wide range 
of physical symptoms, training in relaxation 
techniques can increase diaphragmatic 
breathing and decrease stress experience, 
including cortisol levels and stress. 
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Subsequently, physiological symptoms 
reduce stress (49) and thus affect the level of 
biomarkers. 
This study has some limitations. First, 
current study  is done only with  women 
with MS disease , thus the results  may not 
be generalizable to men with MS disease 
Secondly,  this research has been performed 
on Recurrent-Remission type of MS and is 
not generalizable to other types of the 
disease such as progressive primary, 
progressive secondary, and recurrent 
progressive disease. Moreover, this research 
is not controlled for, and long-term illness 
can contribute to increased interleukin 
levels. 
Despite these limitations, the present study 
showed that acceptance and commitment 
therapy had no significant effect on 
interleukin 12, but CBSM training reduced 
interleukin 12, and these results remained 
consistent in the follow-up period. Based on 
these results, applying CBSM training can 
be effective in regulating biomarkers in MS 
patients and it is suggested that this 
treatment should be used alongside drug 
therapy.  It is suggested that future 
researches be conducted with a larger 
sample size and in a wider population, also 
future studies can be assessed on other types 
of MS including primary-progressive MS, 
secondary-progressive MS and progressive 
Relapsing MS and other auto immune 
diseases such as psoriasis and rheumatoid 
arthritis, The effectiveness of both 
interventions can be examined regarding 
other important biomarkers in MS 
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